Active Ingredient History
Ofatumumab is a fully human monoclonal antibody to CD20, which appears to provide rapid B-cell depletion. Under the brand name Kesimpta, it is approved for the treatment of multiple sclerosis in the United States as well as in the European Union and other regions. Under the brand name Arzerra, it is approved for the treatment of certain types of chronic lymphocytic leukemia (CLL) in the United States. It is sold by Novartis under license from Genmab. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Agammaglobulinemia (Phase 2)
Arthritis, Rheumatoid (Phase 3)
Burkitt Lymphoma (Phase 2)
Endoscopy (Phase 2)
Fatigue (Phase 2)
Fever (Phase 2)
Gonorrhea (Phase 1)
Graft vs Host Disease (Phase 1/Phase 2)
Hodgkin Disease (Phase 2)
Leukemia (Phase 3)
Leukemia, Lymphoid (Phase 1/Phase 2)
Leukemia-Lymphoma, Adult T-Cell (Phase 2)
Leukemia, Prolymphocytic (Phase 1/Phase 2)
Lymphadenopathy (Phase 2)
Lymphocytosis (Phase 2)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Follicular (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 4)
Lymphoma, Large-Cell, Immunoblastic (Phase 2)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 3)
Melanoma (Phase 2)
Multiple Sclerosis (Phase 4)
Multiple Sclerosis, Relapsing-Remitting (Phase 4)
Neoplasms ()
Nephrotic Syndrome (Phase 2)
Paraproteinemias (Phase 2)
Pemphigus (Phase 3)
Squamous Intraepithelial Lesions (Phase 2)
Sweat (Phase 2)
Thrombocytopenia (Phase 2)
Waldenstrom Macroglobulinemia (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue